Picture of Abeona Therapeutics logo

ABEO — Abeona Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Abeona Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

* Abeona Therapeutics Inc  ABEO.OQ  reported a quarterly
adjusted
loss of 63 cents​​ per share for the quarter ended September 30,
lower than the same quarter last year, when the company reported
EPS of -48 cents.  The mean expectation of six analysts for the
quarter was for a loss of 40 cents per share. Wall Street
expected results to range from -45 cents to -36 cents per share.
    * Reported revenue was zero​; analysts expected $100.00
thousand. 
    * Abeona Therapeutics Inc's reported EPS for the quarter was
a
loss of 63 cents​.
    * The company reported a quarterly loss of $30.27 million.
    * Abeona Therapeutics Inc shares had fallen by 3.5% this
quarter and gained 21.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Abeona
Therapeutics Inc is 16.50 
This summary was machine generated from LSEG data November 14 at
02:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.40          -0.63          Missed
 Jun. 30 2024      -0.36          0.19           Beat
 Mar. 31 2024      -0.51          -1.16          Missed
 Dec. 31 2023      -0.47          -0.77          Missed

Recent news on Abeona Therapeutics

See all news